Nadolol (Teva Pharmaceuticals USA Inc)
Welcome to the PulseAid listing for the Nadolol drug offered from Teva Pharmaceuticals USA Inc. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA Inc |
| NON-PROPRIETARY NAME: | Nadolol |
| SUBSTANCE NAME: | NADOLOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2008-11-03 |
| END MARKETING DATE: | 0000-00-00 |
Nadolol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nadolol from Teva Pharmaceuticals USA Inc |
| LABELER NAME: | Teva Pharmaceuticals USA Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2008-11-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-4235_83539758-6c72-4707-9e63-5a2499d3f99a |
| PRODUCT NDC: | 0093-4235 |
| APPLICATION NUMBER: | ANDA074229 |
Other NADOLOL Pharmaceutical Manufacturers / Labelers:
